BioSpace News Archive

Northwest Biotherapeutics, OTCQB: NWBO) -- (“NW Bio”), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that Dr. Marnix Bosch, Chief Technical Officer of NW Bio is presenting at 8:00 pm Wednesday evening, August 29, at the Immuno-Oncology Summit

Physicians’ Education Resource® (PER®), the leading provider of oncology and hematology continuing medical education (CME), announces the full agenda for the 2018 New York Advanced Practice Collaborative.

Global Genes is pleased to announce the celebrities and special guests joining in the fight against rare disease at the 7th Annual RARE Champions of Hope Celebration taking place the evening of October 4, 2018, at Hotel Irvine in Irvine, California.

IPRO is the recipient of a 10-year federal healthcare quality measurement contract that will permit the organization to bid on individual task orders developed by the U.S. Centers for Medicare & Medicaid Services

CyberMDX, a leading healthcare cybersecurity provider delivering visibility and threat prevention for medical devices and clinical networks, today announced that the research group of its company has discovered two security vulnerabilities found in commonly used medical devices: Becton Dickinson (BD)’s Alaris® TIVA Syringe Pump and Qualcomm Life Capsule’s Datacaptor Terminal Server (DTS).

“Today the U.S. Department of Labor issued an opinion letter on living organ donation which protects the job security of living donors who are covered under the Family and Medical Leave Act (FMLA).

Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced that Marty Duvall, chief executive officer, will participate in a panel discussion titled, “Chinese Capital Meets Western Innovation” on Tuesday, September 4, at 11:20 a.m. Eastern Standard Time, at the B. Riley FBR Annual Healthcare Conference.

ConMed Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the Morgan Stanley Global Healthcare Conference at 9:20 a.m. ET on Wednesday, September 12, 2018 in New York, NY.

Ironwood Pharmaceuticals (NASDAQ: IRWD) will present corporate updates at two upcoming investor conferences in September: 2018 Wells Fargo Healthcare Conference on Thursday, September 6, 2018 at 1:55 p.m. ET at the Westin Copley Place in Boston. 16th Annual Morgan Stanley Global Healthcare Conference on Thursday, September 13, 2018 at 11:10 a.m. ET at the Grand Hyatt New York.

Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2018 fourth quarter and full year ended June 30, 2018.